Gossamer Bio

$9.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.43 (-4.44%) As of 4:38 PM UTC today

Why Robinhood?

You can buy or sell Gossamer Bio and other stocks, options, and ETFs commission-free!

About GOSS

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 25, 2015 and is headquartered in San Diego, CA. The listed name for GOSS is Gossamer Bio, Inc. Common Stock.

CEO
Faheem Hasnain
Employees
171
Headquarters
San Diego, California
Founded
2015
Market Cap
690.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
763.21K
High Today
$10.10
Low Today
$9.21
Open Price
$10.00
Volume
194.59K
52 Week High
$16.79
52 Week Low
$7.52

GOSS Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.79 per share
Actual
-$0.88 per share
Replay Earnings Call

You May Also Like

MANT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure